申请人:Ortho Pharmaceutical Corporation
公开号:US04880824A1
公开(公告)日:1989-11-14
Heterocyclic compounds of formulae (I) and (II): ##STR1## where R.sup.1 and R.sup.2 are alkyl, R.sup.3 is H or alkyl, m is 2-5 and Het is a hetercycle such as thiazole, benzothiazole, substituted benzothiazole, pyrazine, triazine, thiadiazole, substituted thiadiazole, pyrimidine or substituted pyrimidine. The compounds are calcium channel blockers useful in the treatment of cardiovascular conditions such as hypertension or angina.
式(I)和(II)的杂环化合物:其中R.sup.1和R.sup.2是烷基,R.sup.3是H或烷基,m为2-5,Het是噻唑、苯并噻唑、取代苯并噻唑、吡啶、三嗪、噻二唑、取代噻二唑、嘧啶或取代嘧啶等杂环。这些化合物是钙通道阻滞剂,可用于治疗心血管疾病,如高血压或心绞痛。